159 related articles for article (PubMed ID: 26957968)
1. Seroprevalence of West Nile Virus specific IgG and IgM antibodies in North-Western and Western provinces of Zambia.
Mweene-Ndumba I; Siziya S; Monze M; Mazaba ML; Masaninga F; Songolo P; Mwaba P; Babaniyi OA
Afr Health Sci; 2015 Sep; 15(3):803-9. PubMed ID: 26957968
[TBL] [Abstract][Full Text] [Related]
2. First sero-prevalence of dengue fever specific immunoglobulin G antibodies in Western and North-Western provinces of Zambia: a population based cross sectional study.
Mazaba-Liwewe ML; Siziya S; Monze M; Mweene-Ndumba I; Masaninga F; Songolo P; Malama C; Chizema E; Mwaba P; Babaniyi OA
Virol J; 2014 Jul; 11():135. PubMed ID: 25078113
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of West Nile Virus among Healthy Blood Donors from Different National Populations Residing in Qatar.
Dargham SR; Al-Sadeq DW; Yassine HM; Ahmed M; Kunhipurayil H; Humphrey JM; Abu-Raddad LJ; Nasrallah GK
Int J Infect Dis; 2021 Feb; 103():502-506. PubMed ID: 33248245
[TBL] [Abstract][Full Text] [Related]
4. Human cases of West Nile Virus infection in north-eastern Italy, 15 June to 15 November 2010.
Barzon L; Pacenti M; Cusinato R; Cattai M; Franchin E; Pagni S; Martello T; Bressan S; Squarzon L; Cattelan A; Pellizzer G; Scotton P; Beltrame A; Gobbi F; Bisoffi Z; Russo F; Palu G
Euro Surveill; 2011 Aug; 16(33):. PubMed ID: 21871228
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of West Nile virus in Iran.
Chinikar S; Shah-Hosseini N; Mostafavi E; Moradi M; Khakifirouz S; Jalali T; Goya MM; Shirzadi MR; Zainali M; Fooks AR
Vector Borne Zoonotic Dis; 2013 Aug; 13(8):586-9. PubMed ID: 23697768
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009.
Pezzotti P; Piovesan C; Barzon L; Cusinato R; Cattai M; Pacenti M; Piazza A; Franchin E; Pagni S; Bressan S; Martello T; Potenza R; Scipioni C; Ammendola R; Breda A; Palu G; Russo F; Rezza G
Euro Surveill; 2011 Mar; 16(10):. PubMed ID: 21435323
[TBL] [Abstract][Full Text] [Related]
7. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors.
Murphy TD; Grandpre J; Novick SL; Seys SA; Harris RW; Musgrave K
Vector Borne Zoonotic Dis; 2005; 5(3):246-51. PubMed ID: 16187893
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection.
Vilibic-Cavlek T; Kristofic B; Savic V; Kolaric B; Barbic L; Tabain I; Peric L; Sabadi D; Miklausic B; Potocnik-Hunjadi T; Zember S; Stevanovic V; Listes E; Savini G
Rev Soc Bras Med Trop; 2018; 51(5):591-595. PubMed ID: 30304263
[TBL] [Abstract][Full Text] [Related]
9. Persistence of West Nile virus-specific antibodies in viremic blood donors.
Prince HE; Tobler LH; Yeh C; Gefter N; Custer B; Busch MP
Clin Vaccine Immunol; 2007 Sep; 14(9):1228-30. PubMed ID: 17652525
[TBL] [Abstract][Full Text] [Related]
10. West Nile Virus Seroprevalence in the Greek Population in 2013: A Nationwide Cross-Sectional Survey.
Hadjichristodoulou C; Pournaras S; Mavrouli M; Marka A; Tserkezou P; Baka A; Billinis C; Katsioulis A; Psaroulaki A; Papa A; Papadopoulos N; Mamuris Z; Tsakris A; Kremastinou J;
PLoS One; 2015; 10(11):e0143803. PubMed ID: 26605539
[TBL] [Abstract][Full Text] [Related]
11. Spread of West Nile virus in Iran: a cross-sectional serosurvey in equines, 2008-2009.
Ahmadnejad F; Otarod V; Fallah MH; Lowenski S; Sedighi-Moghaddam R; Zavareh A; Durand B; Lecollinet S; Sabatier P
Epidemiol Infect; 2011 Oct; 139(10):1587-93. PubMed ID: 21396143
[TBL] [Abstract][Full Text] [Related]
12. Equine seroprevalence of West Nile virus antibodies in the UK in 2019.
Folly AJ; Waller ESL; McCracken F; McElhinney LM; Roberts H; Johnson N
Parasit Vectors; 2020 Nov; 13(1):596. PubMed ID: 33243297
[TBL] [Abstract][Full Text] [Related]
13. A study of West Nile virus infection in Iranian blood donors.
Sharifi Z; Mahmoodian Shooshtari M; Talebian A
Arch Iran Med; 2010 Jan; 13(1):1-4. PubMed ID: 20039761
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus.
Fox JL; Hazell SL; Tobler LH; Busch MP
Clin Vaccine Immunol; 2006 Jan; 13(1):33-6. PubMed ID: 16425997
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of West Nile virus in central nervous system infections of unknown etiology in Ankara, Turkey].
Ergünay K; Aydoğan S; Menemenlioğlu D; Sener B; Lederer S; Steinhagen K; Hasçelik G; Pinar A; Ozkul A; Us D
Mikrobiyol Bul; 2010 Apr; 44(2):255-62. PubMed ID: 20549960
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of West Nile virus-specific antibodies in a cohort of blood donors in northeastern Italy.
Pierro A; Gaibani P; Manisera C; Dirani G; Rossini G; Cavrini F; Ghinelli F; Ghinelli P; Finarelli AC; Mattivi A; Macini PL; Castellani G; Landini MP; Sambri V
Vector Borne Zoonotic Dis; 2011 Dec; 11(12):1605-7. PubMed ID: 21867418
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.
Prince HE; Lapé-Nixon M
Clin Diagn Lab Immunol; 2005 Jan; 12(1):231-3. PubMed ID: 15643014
[TBL] [Abstract][Full Text] [Related]
18. Serological screening of West Nile virus among blood donors in northern Cyprus.
Balaman N; Gazi U; Imir T; Sanlidag T; Ruh E; Tosun O; Ozkul A; Taylan-Ozkan A
J Med Virol; 2020 Aug; 92(8):1035-1039. PubMed ID: 31925797
[TBL] [Abstract][Full Text] [Related]
19. West Nile virus in Canadian blood donors.
Cameron C; Reeves J; Antonishyn N; Tilley P; Alport T; Eurich B; Towns D; Lane D; Saldanha J
Transfusion; 2005 Apr; 45(4):487-91. PubMed ID: 15819667
[TBL] [Abstract][Full Text] [Related]
20. West Nile Virus Seroprevalence Among Blood Donors in Hungary.
Nagy A; Szöllősi T; Takács M; Magyar N; Barabás É
Vector Borne Zoonotic Dis; 2019 Nov; 19(11):844-850. PubMed ID: 31184991
[No Abstract] [Full Text] [Related]
[Next] [New Search]
